[go: up one dir, main page]

WO2018217894A8 - Fluorine-labelled halichondrin derivatives and related methods of synthesis - Google Patents

Fluorine-labelled halichondrin derivatives and related methods of synthesis Download PDF

Info

Publication number
WO2018217894A8
WO2018217894A8 PCT/US2018/034132 US2018034132W WO2018217894A8 WO 2018217894 A8 WO2018217894 A8 WO 2018217894A8 US 2018034132 W US2018034132 W US 2018034132W WO 2018217894 A8 WO2018217894 A8 WO 2018217894A8
Authority
WO
WIPO (PCT)
Prior art keywords
fluorine
labelled
synthesis
related methods
halichondrin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2018/034132
Other languages
French (fr)
Other versions
WO2018217894A1 (en
Inventor
Charles E. Chase
Jing Li
Utpal MAJUMDER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai R&D Management Co Ltd
Original Assignee
Eisai R&D Management Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Management Co Ltd filed Critical Eisai R&D Management Co Ltd
Publication of WO2018217894A1 publication Critical patent/WO2018217894A1/en
Publication of WO2018217894A8 publication Critical patent/WO2018217894A8/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to halichondrin derivatives containing fluorine, e.g., fluorine-18, as well as methods of synthesizing the same.
PCT/US2018/034132 2017-05-24 2018-05-23 Fluorine-labelled halichondrin derivatives and related methods of synthesis Ceased WO2018217894A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762510350P 2017-05-24 2017-05-24
US62/510,350 2017-05-24

Publications (2)

Publication Number Publication Date
WO2018217894A1 WO2018217894A1 (en) 2018-11-29
WO2018217894A8 true WO2018217894A8 (en) 2019-03-14

Family

ID=64395958

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2018/034132 Ceased WO2018217894A1 (en) 2017-05-24 2018-05-23 Fluorine-labelled halichondrin derivatives and related methods of synthesis

Country Status (1)

Country Link
WO (1) WO2018217894A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2830242C1 (en) * 2020-01-22 2024-11-18 Шанхай Сэньхой Медсин Ко., Лтд. Eribulin derivative drug conjugate, method for preparation thereof and use thereof in medicine

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8093410B2 (en) 2007-10-03 2012-01-10 Eisai R&D Management Co., Ltd. Intermediates and methods for the synthesis of halichondrin B analogs
EP3689881B1 (en) 2013-11-04 2022-01-12 Eisai R&D Management Co., Ltd. Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin b
RU2020141025A (en) 2015-05-07 2020-12-28 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. MACROCYCLIZATION REACTIONS AND INTERMEDIATE COMPOUNDS AND OTHER FRAGMENTS USEFUL IN THE SYNTHESIS OF HALIKHONDRIN MACROLIDES
US10676481B2 (en) 2016-02-12 2020-06-09 Eisai R&D Management Co., Ltd. Intermediates in the synthesis of eribulin and related methods of synthesis
KR102404629B1 (en) 2016-06-30 2022-06-02 에자이 알앤드디 매니지먼트 가부시키가이샤 Prince Reaction and Intermediates Useful for Synthesis of Halicondine Macrolides and Analogs thereof
US11542269B2 (en) 2018-01-03 2023-01-03 Eisai R&D Management Co., Ltd. Prins reaction and compounds useful in the synthesis of halichondrin macrolides and analogs thereof
MX2022009044A (en) * 2020-01-22 2022-08-11 Shanghai Senhui Medicine Co Ltd ERIBULIN DERIVATIVE DRUG CONJUGATE, METHOD OF PREPARATION AND APPLICATION OF THE SAME IN MEDICINE.
CN114380840B (en) * 2022-01-27 2024-01-26 江苏慧聚药业股份有限公司 Synthesis of eribulin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009064029A1 (en) * 2007-11-16 2009-05-22 Eisai R & D Management Co., Ltd. Novel intermediate for halichondrin b analog synthesis and novel desulfonylation reaction used for the intermediate
US9278979B2 (en) * 2012-03-30 2016-03-08 Alphora Research Inc. Synthetic process for preparation of macrocyclic C1-keto analogs of halichondrin B and intermediates useful therein
EP3689881B1 (en) * 2013-11-04 2022-01-12 Eisai R&D Management Co., Ltd. Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin b
SG10201805024YA (en) * 2013-12-06 2018-07-30 Eisai R&D Man Co Ltd Methods useful in the synthesis of halichondrin b analogs
EP3191479B1 (en) * 2014-09-09 2020-04-08 Cipla Limited "process for the preparation of macrocyclic ketone analogs of halichondrin b or pharmaceutically acceptable salts and intermediates thereof"

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2830242C1 (en) * 2020-01-22 2024-11-18 Шанхай Сэньхой Медсин Ко., Лтд. Eribulin derivative drug conjugate, method for preparation thereof and use thereof in medicine

Also Published As

Publication number Publication date
WO2018217894A1 (en) 2018-11-29

Similar Documents

Publication Publication Date Title
WO2018217894A8 (en) Fluorine-labelled halichondrin derivatives and related methods of synthesis
PH12019500599A1 (en) Sweet flavor modifier
NZ755865A (en) Water dispersible formulations
NZ702752A (en) Methods for synthesizing amatoxin building block and amatoxins
JO3155B1 (en) Sweet flavor modifier
WO2015195656A3 (en) Synthesis of polycyclic-carbamoylpyridone compounds
WO2016060996A3 (en) Interleukin-15 compositions and uses thereof
WO2017201456A8 (en) Preparation of si-h containing iodosilanes via halide exchange reaction
WO2017139664A8 (en) Intermediates in the synthesis of eribulin and related methods of synthesis
MX2019005855A (en) Powderous formulations.
HK1248069A1 (en) Desacetoxytubulysin h and analogs thereof
WO2017008136A3 (en) Flourinated cbd compounds, compositions and uses thereof
WO2017042828A3 (en) Process for the preparation of selexipag
WO2016100732A3 (en) Commercially viable synthesis of cantharidin and bioactive cantharidin derivatives
CR20200275A (en) Hydroxyisoxazolines and derivatives thereof
MX2009010174A (en) Azaadamantane ester and carbamate derivatives and methods of use thereof.
WO2017064627A3 (en) Process for preparation of eribulin and intermediates thereof
EP4388876A3 (en) Fungicidal nitroanilino substituted pyrazoles
WO2015052568A3 (en) Solid forms of curcumin and derivatives thereof
EA201992196A1 (en) METHOD FOR SYNTHESIS OF ZEOLITE CRYSTALS WITH AN EXTENDING AGENT
WO2021004973A9 (en) Synthesis of a-amanitin and its derivatives
WO2017214423A8 (en) Derivatives of thailanstatin a, methods of treatment and methods of synthesis thereof
PH12017501869A1 (en) (s)-2'-vinyl-abscisic acid derivatives
WO2017046816A3 (en) Process for the preparation of derivatives of benzodioxole
HK1250020A1 (en) Methods for the chemical synthesis of pyrrole-linked bivalent compounds, and compositions thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18806331

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18806331

Country of ref document: EP

Kind code of ref document: A1